Role of TLR9 in anti-nucleosome and anti-DNA antibody production in lpr mutation-induced marine lupus

Journal of Immunology

Volumn 177, Issue 2, 2006, Pages 1349-1354

  Lartigue, Aurelia ^a   Courville, Philippe ^a,b   Auquit, Isabelle ^a   François, Arnaud ^b   Arnoult, Christophe ^a   Tron, François ^a,b   Gilbert, Daniele ^a,b   Musette, Philippe ^a,b  

^a INSERM   (France)

^b HÔPITAL CHARLES NICOLLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; AUTOANTIBODY; B LYMPHOCYTE RECEPTOR; CELL RECEPTOR; DNA ANTIBODY; DOUBLE STRANDED DNA ANTIBODY; NUCLEOSOME ANTIBODY; TOLL LIKE RECEPTOR 9;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ANTIBODY TITER; ANTIGEN RECOGNITION; ARTICLE; AUTOIMMUNE DISEASE; CELL PROLIFERATION; CONTROLLED STUDY; GENE; GENE MUTATION; GENETIC ANALYSIS; KNOCKOUT GENE; KNOCKOUT MOUSE; LPR GENE; MESANGIUM CELL; MOUSE; MOUSE STRAIN; MUTAGENESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN INTERACTION; RECEPTOR BINDING; RECEPTOR BLOCKING; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 33745864016     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.177.2.1349     Document Type: Article

References (44)

1. Kotzin, B. L. 1996. Systemic lupus erythematosus. Cell 85: 303-306.
2. Berden, J. H. 1997. Lupus nephritis. Kidney Int. 52: 538-558.
3. Jacobi, A. M., and B. Diamond. 2005. Balancing diversity and tolerance: lessons from patients with systemic lupus erythematosus. J. Exp. Med. 202: 341-344.
4. + T cell population bearing a distinctive β chain in MRL lpr/lpr mice suggests a role for the Fas protein in peripheral T cell selection. Eur. J. Immunol. 24: 2761-2766.
5. Musette, P., A. Galelli, H. Chabre, P. Callard, W. Peumans, P. Truffa-Bachi, P. Kourilsky, and G. Gachelin. 1996. Urtica dioica agglutinin, a Vβ8.3-specific superantigen, prevents the development of the systemic lupus erythematosus-like pathology of MRL lpr/lpr mice. Eur. J. Immunol. 26: 1707-1711.
6. Amoura, Z., H. Chabre, S. Koutouzov, C. Lotton, A. Cabrespines, J. F. Bach, and L. Jacob. 1994. Nucleosome-restricted antibodies are detected before anti-dsDNA and/or antihistone antibodies in serum of MRL-Mp lpr/lpr and +/+ mice, and are present in kidney eluates of lupus mice with proteinuria. Arthritis. Rheum. 37: 1684-1688.
7. Gilkeson, G. S., A. M. Pippen, and D. S. Pisetsky. 1995. Induction of cross-reactive anti-dsDNA antibodies in preautoimmune NZB/NZW mice by immunization with bacterial DNA. J. Clin. Invest. 95: 1398-1402.
8. Rifkin, I. R., E. A. Leadbetter, L. Busconi, G. Viglianti and A. Marshak-Rothstein. 2005. Toll-like receptors, endogenous ligands, and systemic autoimmune disease. Immunol. Rev. 205: 27-42.
9. Anders, H. J. 2005. A Toll for lupus. Lupus 14: 417-422.
10. Lenert, P. S. 2006. Targeting Toll-like receptor signalling in plasmacytoid dendritic cells and autoreactive B cells as a therapy for lupus. Arthritis Res. Ther. 8: 203.
11. Viglianti, G. A., C. M. Lau, T. M. Hanley, B. A. Miko, M. J. Shlomchik, and A. Marshak-Rothstein. 2003. Activation of autoreactive B cells by CpG dsDNA. Immunity 19: 837-847.
12. lpr mice. FASEB J. 18: 534-536.
13. Anders, H. J., B. Banas, and D. Schlondorff. 2004. Signaling danger: Toll-like receptors and their potential roles in kidney disease. J. Am. Soc. Nephrol. 15: 854-867.
14. Leadbetter, E. A., I. R. Rifkin, A. M. Hohlbaum, B. C. Beaudette, M. J. Shlomchik, and A. Marshak-Rothstein. 2002. Cnromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature 416: 603-607.
15. Means, T. K., E. Latz, F. Hayashi, M, R. Murali, D. T. Golenbock, and A. D. Luster. 2005. Human lupus autoantibody-DNA complexes activate DCs through cooperation of CD32 and TLR9. J. Clin. Invest. 115: 407-417.
16. Shi, X., C. Xie, D. Kreska, J. A. Richardson, and C. Mohan. 2002. Genetic dissection of SLE: SLE1 and FAS impact alternate pathways leading to lymphoproliferative autoimmunity. J. Exp. Med. 196: 281-292.
17. Matsuzawa, A., M. Kimura, T. Muraiso, R. Kominami, and T. Katagiri. 1991. Genotype-restricted lymphoproliferation in autoimmune lpr mice. Eur. J. Immunol. 21: 1535-1542.
18. Aarden, L. A., E. R. de Groot, and T. E. Feltkamp. 1975. Immunology of DNA: III. Crithidia luciliae, a simple substrate for the determination of anti-dsDNA with the immunofluorescence technique. Ann. NY Acad. Sci. 254: 505-515.
19. Christensen, S. R., M. Kashgarian, L. Alexopoulou, R. A. Flavell, S. Akira, and M. J. Shlomchik. 2005. Toll-like receptor 9 controls anti-DNA autoantibody production in murine lupus. J. Exp. Med. 202: 321-331.
20. Tran, T. T., C. F. Reich III, M. Alam, and D. S. Pisetsky. 2003. Specificity and immunochemical properties of anti-DNA antibodies induced in normal mice by immunization with mammalian DNA with a CpG oligonucleotide as adjuvant. Clin. Immunol. 109: 278-287.
21. Chan, T. M., G. Frampton, N. A. Staines, P. Hobby, G. J. Perry, and J. S. Cameron. 1992. Different mechanisms by which anti-DNA MoAbs bind to human endothelial cells and glomerular mesangial cells. Clin. Exp. Immunol. 88: 68-74.
22. Chan, T. M., J. K. Leung, S. K. Ho, and S. Yung. 2002. Mesangial cell-binding anti-DNA antibodies in patients with systemic lupus erythematosus. J. Am. Soc. Nephrol. 13: 1219-1229.
23. Wu, X., and S. L. Peng. 2006. Toll-like receptor 9 signaling protects against murine lupus. Arthritis Rheum. 54: 336-342.
24. Sato, S., O. Takeuchi, T. Fujita, H. Tomizawa, K. Takeda, and S. Akira. 2002. A variety of microbial components induce tolerance to lipopolysaccharide by differentially affecting MyD88-dependent and -independent pathways. Int. Immunol. 14: 783-791.
25. Heikenwalder, M., M. Polymenidou, T. Junt, C. Sigurdson, H. Wagner, S. Akira, R. Zinkernagel, and A. Aguzzi. 2004. Lymphoid follicle destruction and immunosuppression after repeated CpG oligodeoxynucleotide administration. Nat. Med. 10: 187-192.
26. Morel, L., U. H. Rudofsky, J. A. Longmate, J. Schiffenbauer, and E. K. Wakeland. 1994. Polygenic control of susceptibility to murine systemic lupus erythematosus. Immunity 1: 219-229.
27. Mohan, C., E. Alas, L. Morel, P. Yang, and E. K. Wakeland. 1998. Genetic dissection of SLE pathogenesis: SIe 1 on murine chromosome 1 leads to a selective loss of tolerance to H2A/H2B/DNA subnucleosomes. J. Clin. Invest. 101: 1362-1372.
28. Burlingame, R. W., M. L. Boey, G. Starkebaum, and R. L. Rubin. 1994. The central role of chromatin in autoimmune responses to histones and DNA in systemic lupus erythematosus. J. Clin. Invest. 94: 184-192.
29. Richardson, B., L. Scheinbart, J. Strahler, L. Gross, S. Hanash, and M. Johnson. 1990. Evidence of impaired T cell DNA methylation in systemic lupus erythematosus and rheumatoid arthritis. Arthritis Rheum. 33: 1665-1673.
30. Goeckeritz, B. E., M. Flora, K. Witherspoon, Q. Vos, A. Lees, G. J. Dennis, D. S. Pisetsky, D. M. Klinman, C. M. Snapper, and J. J. Mond. 1999. Multivalent cross-linking of membrane Ig sensitizes murine B cells to a broader spectrum of CpG-containing oligodeoxynucleotide motifs, including their methylated counterparts, for stimulation of proliferation and Ig secretion. Int. Immunol. 11: 1693-1700.
31. Wang, Y., and A. M. Krieg. 2003. Synergy between CpG- or non-CpG DNA and specific antigen for B cell activation. Int. Immunol. 15: 223-231.
32. Boule, M. W., C. Broughton, F. Mackay, S. Akira, A. Marshak-Rothstein, and I. R. Rifkin. 2004. Toll-like receptor 9-dependent and -independent dendritic cell activation by chromatin-immunoglobulin G complexes. J. Exp. Med. 199: 1631-1640.
33. Yasuda, K., P. Yu, C. J. Kirschning, B. Schlauer, F. Schmitz, A. Heil, S. Bauer, H. Hochrein, and H. Wagner. 2005. Endosomal translocation of vertebrate DNA activates dendritic cells via TLR9-dependent and -independent pathways. J. Immunol. 174: 6129-6136.
34. Okabe, Y., K. Kawane, S. Akira, T. Taniguchi, and S. Nagata. 2005. Toll-like receptor-independent gene induction program activated by mammalian DNA escaped from apoptotic DNA degradation. J. Exp. Med. 202: 1333-1339.
35. Alexopoulou, L., A. C. Holt, R. Medzhitov, and R. A. Flavell. 2001. Recognition of double-stranded RNA and activation of NF-κ by Toll-like receptor 3. Nature 413: 732-738.
36. Diebold, S. S., T. Kaisho, H. Hemmi, S. Akira, and C. Reis e Sousa. 2004. Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 303: 1529-1531.
37. Andrzejewski, C., Jr., J. Rauch, E. Lafer, B. D. Stollar, and R. S. Schwartz. 1981. Antigen-binding diversity and idiotypic cross-reactions among hybridoma autoantibodies to DNA. J. Immunol. 126: 226-231.
38. Lau, C. M., C. Broughton, A. S. Tabor, S. Akira, R. A. Flavell, M. J. Mamula, S. R. Christensen, M. J. Shlomchik, G. A. Viglianti, I. R. Rifkin, and A. Marshak-Rothstein. 2005. RNA-associated autoantigens activate B cells by combined B cell antigen receptor/Toll-like receptor 7 engagement. J. Exp. Med. 202: 1171-1177.
39. Patole, P. S., D. Zecher, R. D. Pawar, H. J. Grone, D. Schlondorff, and H. J. Anders. 2005. G-rich DNA suppresses systemic lupus. J. Am. Soc. Nephrol. 16: 3273-3280.
40. Dong, L., S. Ito, K. J. Ishii, and D. M. Klinman. 2005. Suppressive oligodeoxynucleotides delay the onset of glomerulonephritis and prolong survival in lupus-prone NZB × NZW mice. Arthritis Rheum. 52: 651-658.
41. Brummel, R., and P. Lenert. 2005. Activation of marginal zone B cells from lupus mice with type A(D) CpG-oligodeoxynucleotides. J. Immunol. 174: 2429-2434.
42. Lenert, P., R. Brummel, E. H. Field, and R. F. Ashman. 2005. TLR-9 activation of marginal zone B cells in lupus mice regulates immunity through increased IL-10 production. J. Clin. Immunol. 25: 29-40.
43. Fillatreau, S., C. H. Sweenie, M. J. McGeachy, D. Gray, and S. M. Anderton. 2002. B cells regulate autoimmunity by provision of IL-10. Nat. Immunol. 3: 944-950.
44. Yin, Z., G. Bahtiyar, N. Zhang, L. Liu, P. Zhu, M. E. Robert, J. McNiff, M. P. Madaio, and J. Craft. 2002. IL-10 regulates murine lupus. J. Immunol. 169: 2148-2155.